Inspira Technologies Oxy Stock Forum

$Inspira Technologies Oxy(IINN.US)$
NEWS
Inspira™ Announces Start of Production of the INSPIRA™ ART100
Inspira™ Technologies OXY B.H.N. (Nasdaq: IINN, IINNW) has announced the start of production of the INSPIRA ART100 medical device. The device is being contract manufactured by a leading technology company and the first batch will be used in initial sites pending FDA approval.

$Inspira Technologies Oxy(IINN.US)$ What has to happen to bring some volume here! Great product! Several pieces of good news over the last few months! Grrrr

$Inspira Technologies Oxy(IINN.US)$ Inspira™ Receives Csa Certification of Compliance to U.S. Standards for the Inspira™ Art100

$Inspira Technologies Oxy(IINN.US)$ Inspira™ Signs Term Sheet for Use of Inspira™ Art100 Device in Organ Transplant Procedures

$Inspira Technologies Oxy(IINN.US)$ Just the tip of the iceberg, now patiently awaiting for upcoming FDA approval

$Inspira Technologies Oxy(IINN.US)$ Inspira And Ennocure Announced Results From Collaborative Development Of Proprietary Bio-Electronic Treatment To Prevent Associated Bloodstream Infections In Patients In Intensive Care Units

$Inspira Technologies Oxy(IINN.US)$
NEWS
Inspira™ and Ennocure In Vitro Study Results Show 100% Prevention of Bacterial Growth that Causes Bloodstream Infections
Inspira Technologies and Ennocure MedTech announce successful results in developing a bio-electronic treatment to prevent bloodstream infections, showing a 75% reduction in bacterial growth within 4 hours and 100% reduction within 24 hours. The technology aims to inhibit bacterial proliferation without the use of antiseptic agents, pote...

$Inspira Technologies Oxy(IINN.US)$ Inspira™ Announces Program to Pioneer the Applicable Use of the INSPIRA™ ART100 Device for an Artificial Womb 4 MINUTES AGO, 8:30 AM EDT VIA PR NEWSWIRE

$Inspira Technologies Oxy(IINN.US)$ On September 13, 2023, the Company announced it had submitted its INSPIRA ART 100, a cardio-pulmonary bypass device, to the U.S. Food and Drug Administration (FDA) via the 510(k) pathway, with potential clearance expected during the first half of 2024 with an expected approval timeline of approximately six months, which is expected in the first half of 2024.
On August 29, 2023, the Company sig...